A detailed history of Nantahala Capital Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 3,130,149 shares of EOLS stock, worth $44.2 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares
3,130,149
Previous 2,824,849 10.81%
Holding current value
$44.2 Million
Previous $45.8 Million 24.49%
% of portfolio
1.74%
Previous 2.72%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$10.84 - $17.45 $3.31 Million - $5.33 Million
305,300 Added 10.81%
3,130,149 $34.6 Million
Q3 2024

Nov 14, 2024

SELL
$10.66 - $17.48 $916,760 - $1.5 Million
-86,000 Reduced 2.95%
2,824,849 $45.8 Million
Q4 2023

Feb 14, 2024

BUY
$7.6 - $10.53 $18.9 Million - $26.2 Million
2,489,629 Added 591.05%
2,910,849 $30.7 Million
Q3 2023

Nov 14, 2023

BUY
$7.15 - $10.2 $3.01 Million - $4.3 Million
421,220 New
421,220 $3.85 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $791M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.